Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Forum Health Launches Groundbreaking AI Technology to Detect Signs of Heart Disease at an Earlier Stage

Phil Hagerman, Forum Health CEO: "Our vision is to use advanced technologies like AI in everything we do. The MCG™ scan uses AI to identify potential heart issues before they escalate into life-threatening conditions. Fond du Lac is the first clinic in our network to launch this technology with great success and we plan to expand it to other clinics."

Forum Health Fond du Lac, a Forum Health national integrative and functional medicine network, has launched the Multifunction Cardiogram™ (MCG™) scan for early detection of heart disease and cardiac abnormalities.

Phil Hagerman, Forum Health CEO: “Our vision is to use advanced technologies like AI in everything we do. The MCG™ scan uses AI to identify potential heart issues before they escalate into life-threatening conditions. Fond du Lac is the first clinic in our network to launch this technology with great success and we plan to expand it to other clinics.”

The MCG™ scan is a preventative measure that can be used in youth and general populations that are increasingly at risk of heart-related disease. Unlike traditional methods that rely on the onset of symptoms, the MCG™ scan uses advanced artificial intelligence (AI) technology to identify a wide range of cardiac concerns, including:

-Coronary artery disease
-Myocarditis
-Microvascular disease
-Rhythm disturbances
-Heart stiffening
-Plaque instabilities
-Occlusions with high sensitivity

Dr. Steven Meress, Forum Health Fond du Lac: “The MCG™ scan is a revolutionary cardiac device. In March 2023, we performed the first round of scans; five months later, 12 out of 12 follow-up scans show improvement. This evidence shows how effective early interventions can be when based off the MCG™ scan and the positive impact on cardiac health.”

The Multifunction Cardiogram™ scan is powered by AI-driven technology, which continuously learns and improves with each test conducted. Each scan is compared to a robust database of more than 200,000 patients with established cardiovascular disease and assigned an objective heart dysfunctional burden score. This score ranks the patient’s heart health, empowering physicians to make informed decisions and develop personalized treatment plans.

IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market

“Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for these technologies is growing due to increasing healthcare needs, advancements in medical devices and rising demand for efficient patient care.”

Advertise With Us

Join Our Family

Of Advertisers
Click Here